- Recent Funding
- Investors
- Cormorant Asset Management
Cormorant Asset Management portfolio
Cormorant Asset Management has 16 portfolio companies on record at Recent Funding, with 4 investments in the last 12 months.
About this page
It led 3 of the 15 rounds it joined. Its most recent investment on record is Dren Bio's $350M funding round in October 2026, alongside Taiho Ventures, General Catalyst, HBM Healthcare Investments and 6 others. By category, its portfolio leans toward Health and bio (16) and Education (1). It has co-invested with OrbiMed, SR One and Janus Henderson Investors, most often OrbiMed (5 rounds).
What Cormorant Asset Management invests in
- Health and bio · 16 · 100%
- Education · 1 · 6%
- Manufacturing and industrial · 1 · 6%
- Logistics and mobility · 1 · 6%
Cormorant Asset Management recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| round · $350M | Taiho Ventures, General Catalyst, HBM Healthcare Investments +6 | ||
| Series B+ · $200M | Redmile Group, Janus Henderson Investors (lead), OrbiMed (lead) +6 | ||
| Series B+ · $90M | Janus Henderson Investors (lead), Duquesne Family Office, Octagon Capital Advisors (lead) +5 | ||
| Series B+ · $115M | LYFE Capital, Kite Pharma, Lifeforce Capital +6 | ||
| Series B+ · $40M | Wellington Management, Novartis Venture Fund, HBM Healthcare Investments +4 | ||
| Series B+ · $100M | DCVC Bio (lead), Emerson Collective, Qiming Venture Partners USA +6 | ||
| Series A · $93M | Forbion Capital Partners, Novo Holdings, Eli Lilly +2 | ||
| Series A · $165M · lead | Vida Ventures (lead), Marshall Wace, Janus Henderson Investors +6 |
How Cormorant Asset Management invests
Cormorant Asset Management portfolio companies
DDren Bio$350Mround · Oct 2026SStar Therapeutics$200MSeries B+ · Oct 2026
EEpicrispr Biotechnologies$90MSeries B+ · Aug 2026
AAspen Neuroscience$115MSeries B+ · Nov 2025
FFore Biotherapeutics$40MSeries B+ · May 2025
UUmoja Biopharma$100MSeries B+ · Jan 2025
OOrbis Medicines$93MSeries A · Jan 2025
TThird Arc Bio$165MSeries A · Jul 2024
AAltruBio$225MSeries B+ · May 2024
MMOMA Therapeutics$150MSeries B+ · May 2022
AArkuda Therapeutics$64MSeries B+ · Feb 2022
SStrata Oncology$90MSeries B+ · Jul 2021
NnChroma Biobacker
EEnsomabacker
VVelosbiobacker
GGC Therapeuticsbacker
| Company | Round with Cormorant Asset Management | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
round · $350M | $415M | Oct 29, 2026 round |
Health and bio |
Series B+ · $200M | $415M | Oct 23, 2026 Series B+ |
Health and bio |
Series B+ · $90M | $158M | Aug 11, 2026 Series B+ |
Health and bio |
Series B+ · $115M | $339M | Nov 20, 2025 Series B+ |
Health and bio |
Series B+ · $40M | $182.4M | Jul 8, 2026 Series B+ |
Health and bio |
Series B+ · $100M | $363M | Jan 14, 2025 Series B+ |
Health and bio |
Series A · $93M | $121M | Jan 6, 2025 Series A |
Health and bio |
Series A · $165M · lead | $217M | Feb 4, 2026 Series A |
Health and bio |
Series B+ · $225M | $288M | May 21, 2024 Series B+ |
Health and bio |
Series B+ · $150M | $236M | May 10, 2022 Series B+ |
Health and bio |
Series B+ · $64M · lead | $108M | Feb 10, 2022 Series B+ |
Health and bio |
Series B+ · $90M | $128M | Jul 28, 2021 Series B+ |
Health and bio |
backer | $75M | Dec 12, 2024 round |
Health and bio |
backer | $50M | May 16, 2023 Series B+ |
Health and bio |
backer | $58M | Aug 2, 2026 Series B+ |
Health and bio |
backer | undisclosed | Sep 23, 2024 Series A |
Most frequent co-investors
OOrbiMed5 shared rounds · last Oct 29, 2026
SSR One3 shared rounds · last Oct 29, 2026
JJanus Henderson Investors3 shared rounds · last Oct 23, 2026
WWellington Management3 shared rounds · last May 1, 2025
MMission BioCapital2 shared rounds · last Oct 29, 2026
HHBM Healthcare Investments2 shared rounds · last Oct 29, 2026
RRA Capital Management2 shared rounds · last Oct 23, 2026
SSoleus Capital2 shared rounds · last Oct 23, 2026
SS322 shared rounds · last Nov 20, 2025
NNovartis Venture Fund2 shared rounds · last May 1, 2025
33B Future Health Fund2 shared rounds · last May 1, 2025
MMedicxi2 shared rounds · last May 1, 2025
Similar investors
MMaverick Ventures16 companies · 4 deals in 12 moBBling Capital16 companies · 3 deals in 12 mo
FForesite Capital16 companies · 3 deals in 12 mo
GGoldman Sachs Alternatives17 companies · 12 deals in 12 mo
KKorea Investment Partners17 companies · 7 deals in 12 mo
DDrive Capital17 companies · 6 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 15 rounds on Recent Funding that name Cormorant Asset Management. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Cormorant Asset Management, which is a subset of its real portfolio. API: /api/v1/investors/cormorant-asset-management (get a free API key). More: the most active VC firms and new venture capital funds.
The week's top funded startups and market insights, in your inbox every Monday.
Unsubscribe anytime · privacy